Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q1- Text added to 2022 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
automatically, basic, Biotech, board, claimed, committed, computation, Core, CTA, Denmark, dollar, endpoint, expedite, family, finally, growth, health, incorporating, Individual, induced, inflation, input, institutional, invoiced, iPSC, macroeconomic, monetary, monitor, movement, mutual, National, nivolumab, numerator, order, oversight, pluripotent, reach, recession, review, site, slower, stem, tighter, withdrawn
Removed:
European, treating
Valuein 2022 Q1 filing- Value in 2022 Q2 filing
Original filings
Filing view